Kamal Therapeutics, Inc.

CIK 1880064 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kamal Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 24, 2025D0001880064-25-000004
Oct 11, 2022D/A0001880064-22-000001
Aug 27, 2021D0001880064-21-000001